Abstract
The aim of this study is to introduce Hamiltonian path to analyze functional connectivity of brain default mode networks (DMNs). Firstly, the brain DMNs in resting state are constructed with the employment of functional Magnetic Resonance Imaging (fMRI) data. Then, the Dijkstra algorithm is used to calculate the shortest path length of the node which represents each brain region, and the Hamiltonian path of the default network is solved through the improved adaptive ant colony algorithm. Finally, complex network analysis methods are introduced to discuss the node and network properties of brain functional connectivity in both normal subjects and stroke patients. The experimental result demonstrated that there are some significant differences in the properties of the DMNs between stroke patients and normal subjects, especially the length of Hamiltonian path. It also verifies the effectiveness on studying the functional connectivity of the brain DMNs by applying the proposed method of Hamiltonian path.
Keywords: Ant colony algorithm, brain functional connectivity, complex network, default mode networks, functional magnetic resonance imaging, Hamiltonian path.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Functional Connectivity Analysis of Brain Default Mode Networks Using Hamiltonian Path
Volume: 16 Issue: 1
Author(s): Zhuqing Jiao, Kai Ma, Huan Wang, Ling Zou and Jianbo Xiang
Affiliation:
Keywords: Ant colony algorithm, brain functional connectivity, complex network, default mode networks, functional magnetic resonance imaging, Hamiltonian path.
Abstract: The aim of this study is to introduce Hamiltonian path to analyze functional connectivity of brain default mode networks (DMNs). Firstly, the brain DMNs in resting state are constructed with the employment of functional Magnetic Resonance Imaging (fMRI) data. Then, the Dijkstra algorithm is used to calculate the shortest path length of the node which represents each brain region, and the Hamiltonian path of the default network is solved through the improved adaptive ant colony algorithm. Finally, complex network analysis methods are introduced to discuss the node and network properties of brain functional connectivity in both normal subjects and stroke patients. The experimental result demonstrated that there are some significant differences in the properties of the DMNs between stroke patients and normal subjects, especially the length of Hamiltonian path. It also verifies the effectiveness on studying the functional connectivity of the brain DMNs by applying the proposed method of Hamiltonian path.
Export Options
About this article
Cite this article as:
Jiao Zhuqing, Ma Kai, Wang Huan, Zou Ling and Xiang Jianbo, Functional Connectivity Analysis of Brain Default Mode Networks Using Hamiltonian Path, CNS & Neurological Disorders - Drug Targets 2017; 16 (1) . https://dx.doi.org/10.2174/1871527314666161124120040
DOI https://dx.doi.org/10.2174/1871527314666161124120040 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Experimental and Theoretical Approach to Understand Fever, DENF & its Cure
Infectious Disorders - Drug Targets Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy
Current Pharmaceutical Design Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries
CNS & Neurological Disorders - Drug Targets Structure and Function of β -1,4-Galactosyltransferase
Current Drug Targets The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery Autoantibodies in Autoimmune Diseases
Current Pharmaceutical Design Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment
Current Topics in Medicinal Chemistry [177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Current Radiopharmaceuticals Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases
Current Pharmaceutical Design Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities
Current Pharmaceutical Design Histone Deacetylase Inhibitors: From Chromatin Remodeling to Experimental Cancer Therapeutics
Current Medicinal Chemistry MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics
Current Pharmaceutical Design Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights
Current Neuropharmacology Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine The Professional Phagocyte Dictyostelium discoideum as a Model Host for Bacterial Pathogens
Current Drug Targets Compounds Derived from Epigallocatechin-3-Gallate (EGCG) as a Novel Approach to the Prevention of Viral Infections
Inflammation & Allergy - Drug Targets (Discontinued) Interest of α2-Adrenergic Agonists and Antagonists in Clinical Practice: Background, Facts and Perspectives
Current Topics in Medicinal Chemistry In the Rush for Green Gold: Can Green Tea Delay Age-Progressive Brain Neurodegeneration?
Recent Patents on CNS Drug Discovery (Discontinued) Stimuli-Responsive Nanocarriers for Drug Delivery to the Central Nervous System
Current Nanoscience New Target Therapies for Brain Metastases from Breast Cancer
Current Cancer Drug Targets